Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q&A: Former CDRH Director Dan Schultz On Communication Issues, 510(k)s

This article was originally published in The Gray Sheet

Executive Summary

For former FDA device center director Dan Schultz, his new job since leaving the agency may feel a bit familiar: explaining FDA's sometimes convoluted processes to frustrated device firms

You may also be interested in...

Schultz Exits: Pressures From Inside And Out Catch Up With CDRH Director

At least a handful of disgruntled employees, members of Congress champing at the bit and a new reformist FDA administration were apparently the undoing of Dan Schultz's leadership of CDRH

FDA Can’t Inspect Its Way Out Of Import Safety Problems – Schultz, Sharfstein

Increasing the number of foreign device facility inspections alone will not dramatically improve FDA import safety, agency leaders say

Biogen’s Recipe For Success In Knowledge Management

Biogen’s “recipe-driven qualification” knowledge management program standardizes data collection and reporting in the laboratory, with efficiency gains of 66%.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts